Lee, H.W.; Seo, H.S.; Yeom, S.-Y.; Kim, S.-N.; Kim, C.R.; Park, D.-H.; Park, W.; Choy, Y.B.; Park, C.G.; Seo, S.I.
Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma. Int. J. Mol. Sci. 2022, 23, 12634.
https://doi.org/10.3390/ijms232012634
AMA Style
Lee HW, Seo HS, Yeom S-Y, Kim S-N, Kim CR, Park D-H, Park W, Choy YB, Park CG, Seo SI.
Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma. International Journal of Molecular Sciences. 2022; 23(20):12634.
https://doi.org/10.3390/ijms232012634
Chicago/Turabian Style
Lee, Hye Won, Hee Seung Seo, Seon-Yong Yeom, Se-Na Kim, Cho Rim Kim, Dae-Hwan Park, Wooram Park, Young Bin Choy, Chun Gwon Park, and Seong Il Seo.
2022. "Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma" International Journal of Molecular Sciences 23, no. 20: 12634.
https://doi.org/10.3390/ijms232012634
APA Style
Lee, H. W., Seo, H. S., Yeom, S.-Y., Kim, S.-N., Kim, C. R., Park, D.-H., Park, W., Choy, Y. B., Park, C. G., & Seo, S. I.
(2022). Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma. International Journal of Molecular Sciences, 23(20), 12634.
https://doi.org/10.3390/ijms232012634